Regenerative Medicine and Nanomedicine Initiative (RMNI)
Overview
The Regenerative Medicine and Nanomedicine Initiative is one of the four main
CIHR large initiatives. It is co-led by
the Institute of Neurosciences, Mental Health and Addictions and the
Institute of Genetics. The fundamental goal of this initiative is the development of meaningful multi-disciplinary research approaches to regenerative medicine and nanomedicine. This necessitates the continued integration of the physical, engineering, computational and chemical sciences, among others, with the health sciences. These approaches need to balance consideration of the social, cultural and ethical impacts of these novel technologies with key rehabilitation and accessibility issues, as well as the potential economic costs of such treatments. Research into the maintenance of health or prevention of disease and degeneration is also encompassed by this initiative.
The commitment to supporting truly innovative and leading edge multi-disciplinary research directed against key health research problems makes up the core of this strategic initiative.
